Regulatory FAQs & common concerns for cell & gene therapy raw & starting materials - ANIMATION
Cell & Gene Therapy Insights 2020; 6(8)
In cell and gene therapy, materials matter. However, misconceptions abound, exacerbating a lack of harmonization and standardization in key areas. For example, uncertainty around quality grades at the various stages of R&D is commonplace, and everyday terms are frequently misinterpreted or misunderstood, with potentially damaging ramifications for advanced therapy development, manufacturing and commercialization.
Here, we have put together a 2-minute animation highlighting the key dos and don'ts from our expert panel.